Panagiotis Chatzis

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome.

The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome.

Journal: Folia medica

Published: October 16, 2017

Prenatal diagnosis of 1p34.3 interstitial microdeletion by aCGH in a fetus with jaw bone abnormalities.

Prenatal diagnosis of 1p34.3 interstitial microdeletion by aCGH in a fetus with jaw bone abnormalities.

Journal: Molecular cytogenetics

Published: July 27, 2016

Concealed heterotopic pregnancy at 12 weeks, with no coexisting risk factors: Lessons to be learned.

Concealed heterotopic pregnancy at 12 weeks, with no coexisting risk factors: Lessons to be learned.

Journal: The journal of obstetrics and gynaecology research

Published: December 04, 2015

Metastatic cervical carcinoma presenting as psoas abscess, after a radical total hysterectomy.

Metastatic cervical carcinoma presenting as psoas abscess, after a radical total hysterectomy.

Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Published: December 24, 2013

Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.

Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.

Journal: Hormones (Athens, Greece)

Published: November 27, 2013

Associations of menstrual cycle irregularities with age, obesity and phenotype in patients with polycystic ovary syndrome.

Associations of menstrual cycle irregularities with age, obesity and phenotype in patients with polycystic ovary syndrome.

Journal: Hormones (Athens, Greece)

Published: July 28, 2013

The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.

The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.

Journal: Clinical endocrinology

Published: May 14, 2013

The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome.

The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome.

Journal: European journal of endocrinology

Published: April 06, 2013

Minimally invasive techniques for female stress urinary incontinence, how, why, when.

Minimally invasive techniques for female stress urinary incontinence, how, why, when.

Journal: Archives of gynecology and obstetrics

Published: March 26, 2013

Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.

Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.

Journal: Endocrine

Published: February 06, 2013

Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome.

Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome.

Journal: European journal of endocrinology

Published: October 31, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026